Nucleic Acid–Based Therapies — The Next Frontier in Treating Dyslipidemias
Canadian Journal of Cardiology · 2026
DOI: 10.1016/j.cjca.2026.01.026 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Canadian Journal of Cardiology, 2026. Verfasst von Robert A Hegele. Beteiligte Einrichtung: Department of Medicine, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada. Electronic address: hegele@robarts.ca. Hauptthemen laut MEDLINE: Dyslipidemias, Genetic Therapy, Gene Editing. Die Arbeit nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada. Electronic address: hegele@robarts.ca.
Zitieren
APA
Hegele, R. A. (2026). Nucleic Acid–Based Therapies — The Next Frontier in Treating Dyslipidemias. Canadian Journal of Cardiology. https://doi.org/10.1016/j.cjca.2026.01.026
Vancouver
Hegele RA. Nucleic Acid–Based Therapies — The Next Frontier in Treating Dyslipidemias. Canadian Journal of Cardiology. 2026. doi:10.1016/j.cjca.2026.01.026
BibTeX
@article{Hegele2026,
author = {Hegele, Robert A},
title = {Nucleic Acid–Based Therapies — The Next Frontier in Treating Dyslipidemias},
journal = {Canadian Journal of Cardiology},
year = {2026},
doi = {10.1016/j.cjca.2026.01.026}
}
EUVIMED